Skip to main content
SpringerLink
Log in

Schwangerschaftsabbruch

  • Chapter
Die Geburtshilfe

  • 326 Accesses

Zusammenfassung

Der Schwangerschaftsabbruch oder induzierte Abort wurde noch vor 25 Jahren in der allgemeinen Terminologie als krimineller Abort bezeichnet. Seitdem sind die Abortgesetze in vielen Ländern liberalisiert worden. Daraufhin sank die mütterliche Mortalität, und die Zahl der legalen Aborte stieg an. Im Gegensatz zu Japan, China und der damaligen Sowjetunion wurde der induzierte Abort in den westlichen Ländern nur als eine Notlösung und nicht als eine Methode der Familienplanung angesehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abortion Surveillance: preliminary data United States (1991) MMWR 43: 42–44

    Google Scholar 

  • Alan Guttmacher Institute (1996) Facts in brief: induced abortion. The Alan Guttmacher Institute, New York

    Google Scholar 

  • AMA Report (1997) Concerning H.R. 1122, the »Partial Abortion Act of 1997«

    Google Scholar 

  • Ashok PW, Penney GC, Flett GM et al. (1998) An effective regimen for early abortion: a report of 2000 consecutive cases. Hum Reprod 13: 2962–2965

    Article  PubMed  CAS  Google Scholar 

  • Atrash HK, on HW, Smith JC (1990) Legal abortion in the US, trends and mortality. Contemp Ob Gyn 35: 58–69

    Google Scholar 

  • Baird DT, Sukcharoen N, Thong KJ (1995) Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 10: 1521–1527

    Article  PubMed  CAS  Google Scholar 

  • Beaulieu EE, Segal SJ (eds) (1985)The antiprogesterone steroid RU 486 and human fertility control. Plenum, New York

    Google Scholar 

  • Beller FK (1972) Pathophysiologische Aspekte des septischen Schocks während der Schwangerschaft. Z Rechtsmedizin 70: 55–67

    Article  CAS  Google Scholar 

  • Beller FK (1996) Wie klein ist zu klein, wie groß ist zu groß?. Frauenarzt 37: 929–933

    Google Scholar 

  • Beller FK, DeProsse CHA (1992) The confusion of trimester and viability and the consequences for the abortion law. J Reprod Med 37: 537–540

    PubMed  CAS  Google Scholar 

  • Beller FK, Zlatnik P (1994) Medical aspects of the beginning of human life. In: Beller FK, Weir RF (eds) The beginning of human life. Kluwer, Dordrecht, PP 3–19

    Chapter  Google Scholar 

  • Binkin N (1986) Trends in induced legal abortion morbidity and mortality. Clin Obst Gynecol 13: 83–93

    CAS  Google Scholar 

  • Bottoms SF, Paul RH, lams JD et al. (1997) Obstetrical determinants of neonatal survival: influence of willingness to perform cesarean section delivery on survival of extremly low-birth-weight. Am J Obstet Gynecol 176: 960–966

    Article  PubMed  CAS  Google Scholar 

  • Calder L, Pempleton A (1995) Induction of abortion with mifepriston (RU 486) and oral or vaginal misoprostol. N Engl J Med 332: 983–987

    Article  PubMed  Google Scholar 

  • Carbonell JLI, Varela L, Velazco A et al. (1999) Early abortion with 800 ug of misopristol by the vaginal route. Contraception 59: 219–225

    Article  Google Scholar 

  • Cates W Jr, Grimes DA (1981) Morbidity and mortality of abortion in the United States. In: Hofgeson JE (ed) Abortion and sterilization. Medical and social aspects. Academic Press, New York, pp 155–180

    Google Scholar 

  • CDC (1980) Abortion surveillance 1978. Centers for Disease Control, Atlanta/GA

    Google Scholar 

  • Chervenak FA, McCullogh LB, Campbell S (1995) Is third trimester abortion justified?. Br J Obstet Gynaecol 102: 434–435

    Article  PubMed  CAS  Google Scholar 

  • Creinin MD, Darney PD (1993) Methotrexate and misoprostol for early abortion. Contraception 48: 339–342

    Article  PubMed  CAS  Google Scholar 

  • Creinin MD, Moyer R, Guido R (1997) Misoprostol for medical evaluation of early pregnancy. Obstet Gynecol 89: 768–72

    Article  PubMed  CAS  Google Scholar 

  • Creinin MD, Pymar HC (2001) Mifepristone 100 mg in abortion regimens. Obstet Gynecol 98: 434–439

    Article  PubMed  CAS  Google Scholar 

  • El-Rafaey H, Rasekar D, Abdalla M (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332: 983–987

    Article  Google Scholar 

  • El-Rafaey H, Rajasekar D, Abdalla M, Calder L, Templeton A (1995) Induction of abortion with mifepristone (RU 486)

    Google Scholar 

  • Fathalla MF (1997) Gesellschaft und menschliche Reproduktion. Festrede FIGO-Kongress Kopenhagen, Okt. 1997

    Google Scholar 

  • Glasier AKJ, Thong M, Dewar M, Makie DT, Baird DT (1992) Mifepristone (RU 468) compared with high dose estrogen and progestogen for emergency postcoital contraception. N England J Med 327: 1041–1044

    Article  CAS  Google Scholar 

  • Graeves D, Evans M, Morgan D, Pickering N, Upton M (1992) Bioethics in the United Kingdom and Ireland, 1989–91. In: Lustig A (ed) Bioethics Yearbook, vol 2B. Kluwer, Dordrecht, pp 127–152

    Chapter  Google Scholar 

  • Grimes DA, Cook RJ (1992) Mifepristone (RU 486), an abortificiant to prevent abortion. N Engl J Med 327: 1088–1089

    Article  PubMed  CAS  Google Scholar 

  • Grimes DA, Schulz KF, Cates W Jr (1984) Prophylactic antibiotics for curettage. Am J Obstet Gynecol 150: 689–1000

    PubMed  CAS  Google Scholar 

  • Grimes DA, Stubblefield PG (1999) A clinician guide to medical and surgical abortion. Churchill Livingstone, New York, pp 192–216

    Google Scholar 

  • Grou F, Rodrigues I (1994) The morning-after pill — how long after?. Am J Obstet Gynecol 171: 1529–1534

    PubMed  CAS  Google Scholar 

  • Hankins I, Gary DV (1994) Operative obstetrics. Appleton & Lange, Stamfort/CT, p 614

    Google Scholar 

  • Hausknecht RU (1995) Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 333: 537–540

    Article  PubMed  CAS  Google Scholar 

  • Henshaw SK, Morrow E (1990) Induced abortion, a world review. Fam Plann Perspect 22: 76–120

    Article  PubMed  CAS  Google Scholar 

  • Hepp H (1996) Pränatalmedizin und reformierter § 218a StGB — oder: die versteckte Indikation. Gynäkologe 29: 407–411

    Article  Google Scholar 

  • Jain JK, Meckstroh M, Park M (2000) A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination. Amer J Obstet Gynecol 60: 353–356

    Google Scholar 

  • Jurema M, Wallach EE, Blumenthal PD (2001) Mifepristone for medical abortion: A review. Biweekly Rev Clin Ob Gyn 21: 1–5

    Google Scholar 

  • Koonin LM, Smith JC, Ramick M, Lawson HW (1992) Abortion surveillance United States 1989. MMWR 41/5: 1–33

    Google Scholar 

  • Koonin LM, Strauss LT, Chrisman CE et al. (1999) Abortion surveillance — United States 1966. MMWR Morb Mortal WKLY REP 48: 1–42

    Google Scholar 

  • Lawson HW, Atrash HK, Saftlas AF, Finch EL (1981) Abortion surveillance United States 1984–1985. MMWR Surv Sum 38 (SS-2): 11

    Google Scholar 

  • Lawson HW, Frye A, Atrash H et al. (1994) Abortion mortality United States 1972–1987. Am J Obstet Gynecol 171: 1365–2000

    PubMed  CAS  Google Scholar 

  • Lindblom B (1992) Ectopic pregnancy — laparoscopic and medical treatment. Curr Opin Obstet Gynecol 4: 400–405

    Article  PubMed  CAS  Google Scholar 

  • Lippes J, Malik T, Tatum HJ (1976) The post coital copper T. Adv Plann Parenthood 11: 24–100

    CAS  Google Scholar 

  • MacIsaac L, Creinin MD (2000) Early surgical abortion an alternative and backup for medical abortion. Amer J Obstet Gynecol 183: 76–83

    Article  Google Scholar 

  • Mahler H (1987) The safe motherhood initiative: a call to action. Lancet 1: 668–670

    Article  PubMed  CAS  Google Scholar 

  • McCullogh LB, Chervenak FA (1994) Ethics in obstetrics and gynecology. Oxford University Press

    Google Scholar 

  • McKinley C, Thong KJ, Baird DT (1993) The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 8: 1502–1505

    PubMed  CAS  Google Scholar 

  • Melby M, Wohlfahrt J, Olsen J, Frisch M, Westergaard T, Hellweg Larsen KH, Andersen PK (1997) Induced abortion and the risk of breast cancer. N England J Med 336: 81–85

    Article  Google Scholar 

  • Müller TJ, Backe A, Rempen A (1996) Vorzeitige Schwangerschaftsbeendigung im II. und III.Trimenon. Geburtsh Frauenheilk 56: 234–238

    Article  PubMed  Google Scholar 

  • Mund M (2001) Der medikamentöse Schwangerschaftsabbruch mit Mifepriston. Frauenarzt 42: 952

    Google Scholar 

  • Ngai SW, Yeung KCA, Lao T (1996) Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study. Br J Obstet Gynaecol 103: 1120–1123

    Article  PubMed  CAS  Google Scholar 

  • Paul M, Schaff E, Nichols MT (2000) The roles of clinical assessment, human chorionic gonadotropin assay and ultrasonography in medical practice. Am J Obstet Gynecol 183: 34–43

    Article  Google Scholar 

  • Paul M, Lackie E, Mitchell C et al. (2002) Is pathology examination useful after early surgical abortion. Obstet Gynecol 99: 567–571

    Article  PubMed  Google Scholar 

  • Peyron R, Aubry E, Targosz V, Silvestre L, Renault M, Elkik F et al. (1993) Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N England J Med 328: 1509–1513

    Article  CAS  Google Scholar 

  • Pirruccello EP, Newhall MD, Winikoff R (2000) Abortion with mifepristone and misoprostol: Regimens acceptability and future directions. Maer J Obstet Gynecol 183: 44–53

    Article  Google Scholar 

  • Policar MJ, Pollack AE (eds) (1995) Clinical training curriculum in abortion practice. National Abortion Federation, Washington DC

    Google Scholar 

  • Querido L, Haspels AA (1990) Late second trimester abortion with 16, 16 dimethyl transdelta 2-PGE1 methylester (Gemeprost). Contraception 42: 43–49

    Article  PubMed  CAS  Google Scholar 

  • Rath W, Osmers K, Stuhlsatz HW, Adelmann-Grill BC (1996) Geburtseinleitung mit Prostaglandinen. Nutzen und Risiken. In Rath W (Hrsg) Fortschritte in der medikamentösen Geburtseinleitung, 2. Aufl. HUF, Mühlheim, S 39

    Google Scholar 

  • Ross GT, Goldstein M, Hertz R et al. (1965) Sequential use of methotrexate and actinomycin D in the treatment of metastatic chorion carcinoma and related throphoblastic disease in women. Am J Obstet Gynecol 150: 189

    Google Scholar 

  • Rymar HC, Creinin MD (2000) Alternatives to mifepristone regimens for medical abortion. Amer J Obstet Gynecol 183: 54–64

    Article  Google Scholar 

  • Schaff EA, Penmeetsa U, Eisinger STH, Franks P (1997) Methotrexate — a single agent for abortion. J Reprod Med 42: 56–60

    PubMed  CAS  Google Scholar 

  • Schaff EA, Stadalius LS, Eisinger SH et al. (1997) Vaginal misoprostol at home after mifepristone. J Fam Pract 44: 353–360

    PubMed  CAS  Google Scholar 

  • Schneider D, Halparin R, Langer R, Caspi E, Bukowski I (1996) Abortion at 18–22 weeks by laminaria dilatation and evacuation. Obstet Gynecol 88: 412–414

    Article  PubMed  CAS  Google Scholar 

  • Schüssler B (1997) Prostaglandinanwendung in Gynäkologie und Geburtshilfe. Standard-Therapiekonzepte und neue Alternativen. Frauenheilkd Aktuell 1: 4–8

    Google Scholar 

  • Spitz IM, Bardin CW, Benton L et al. (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338: 1241–1247

    Article  PubMed  CAS  Google Scholar 

  • Stoval TG, Ling FW (1993) Single dose methotrexate: an expanded dilatation trail. Am J Obstet Gynecol 48: 339–348

    Google Scholar 

  • Stubblefield PG (1986) Pregnancy termination. In: Gabbe SG, Niebyl JR, Simpson JL (eds) Obstetrics. Normal and problem pregnancy. Churchill Livingstone, New York, p 1051

    Google Scholar 

  • Task Force (1999) Postovulatory Methods for Fertility Regulation: Randomised controll trial of levonogestrel vs the Yupze regimen of combined oral contraception for emergency contraception. Lancet 352: 428–433

    Google Scholar 

  • Tietze C, Lewit S (1972) Joint program for the study of abortion early medical complication of legal abortion. Stud Fam Plann 3: 97–101

    Article  Google Scholar 

  • Thong KJ, Baird DT (1992) An open study comparing two regimens of Gemeprost for the termination of pregnancy in the second trimester. Acta Obstet Gynecol Scand 71: 191–196

    Article  PubMed  CAS  Google Scholar 

  • Webb AMC (1991) Alternative treatment in oral postcoital contraception, interim results. Adv Contracept 7: 271–275

    Article  PubMed  CAS  Google Scholar 

  • Westfall JM, Sophocles A, Burggraf H et al. (1998) Manual vacuum aspiration for trimester abortion. Arch Fam Med 7: 559–562

    Article  PubMed  CAS  Google Scholar 

  • WHO (1991) Pregnancy termination with mifepristone and gemeprost. A multicenter comparison between repeated doses and a single dose of mifepristone. Fertil Steril 56: 32–40

    Google Scholar 

  • Wiebe ER (1997) Abortion induced with methotrexate and misoprostol. A comparison of various protocolls. Contraception 55: 159–163

    Article  PubMed  CAS  Google Scholar 

  • Wiebe ER (1999) Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion. Amer J Obst Gynecol 181: 149–152

    Article  CAS  Google Scholar 

  • Wiebe ER, Dunns G, Gilbert E et al. (2002) Comparison of abortions induced by methotrexate or Mifepristone followed by Misoprostol. Obstet Gynecol 99: 813–819

    Article  PubMed  CAS  Google Scholar 

  • Winkler M, Rath W (1997) Aktuelles Vorgehen bei der vorzeitigen Schwangerschaftsbeeendigung mit Prostaglandinen im II. und III.Trimenon. Z Geburtsh Neonatol 201: 39–43

    CAS  Google Scholar 

  • Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM (1991) Mid second trimester labor induction, concentrated oxytocin compared with Prostaglandin E2 Supp. Obstet Gynecol 77: 297–300

    Article  PubMed  CAS  Google Scholar 

  • Wood SL, Brain PH (2002) Medical management of missed abortion. A randomized clinical trial. Obstet Gynecol 99: 563–566

    Article  PubMed  CAS  Google Scholar 

  • Yupze A, Smith RP, Rademaker AW (1982) A multicenter clinical trial investigation employing ethinylestradiol combined with dl-norgestrel as a postcoital contraceptive agent. Fertil Steril 37: 508–513

    Google Scholar 

Download references

Authors
  1. F. K. Beller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ehem. Direktor der Universitätsfrauenklinik am Inselspital Bern, Ahornweg 4, 3122, Kehrsatz, Schweiz

    Henning Schneider

  2. Abteilung für Geburtshilfe und Gynäkologie, Universitätsklinik für Frauenheilkunde, Währinger Gürtel 18-20, 1090, Wien, österreich

    Peter Husslein

  3. Abteilung für Perinatalmedizin Frauenklinik und Poliklinik des Klinikums rechts der Isar, Universität der Technischen Universität München, Ismaninger Straße 22, 81675, München

    Karl-Theo M. Schneider

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Beller, F.K. (2004). Schwangerschaftsabbruch. In: Schneider, H., Husslein, P., Schneider, KT.M. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18574-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18574-8_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-30522-4

  • Online ISBN: 978-3-642-18574-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation